Ridloff Elena sold KYMR
May 11, 2026 · Form 4 insider transaction
Ridloff Elena sold 3,000 shares of Kymera Therapeutics, Inc. at $87.00 per share, a transaction worth $261.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,000
Price
$87.00
Total value
$261.0K
InsiderRidloff Elena
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 11, 2026
Filing dateMay 11, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 11, 2025 adopted by the reporting person.